
Industry
Medical - Devices
Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics. Its Aquadex FlexFlow system includes a console, disposable blood set, and catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors primarily in Austria, Brazil, Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.
Loading...
Open
1.14
Mkt cap
5.1M
Volume
33K
High
1.17
P/E Ratio
-0.14
52-wk high
16.80
Low
1.14
Div yield
N/A
52-wk low
0.92
Portfolio Pulse from Benzinga Newsdesk
January 04, 2024 | 8:14 pm
Portfolio Pulse from Benzinga Newsdesk
January 04, 2024 | 8:12 pm
Portfolio Pulse from Benzinga Insights
December 27, 2023 | 9:31 pm
Portfolio Pulse from Benzinga Insights
December 21, 2023 | 9:31 pm
Portfolio Pulse from Benzinga Insights
December 11, 2023 | 2:43 pm
Portfolio Pulse from Benzinga Newsdesk
November 28, 2023 | 1:09 pm
Portfolio Pulse from Benzinga Insights
November 27, 2023 | 1:07 pm
Portfolio Pulse from Benzinga Insights
November 20, 2023 | 2:44 pm
Portfolio Pulse from Benzinga Newsdesk
November 08, 2023 | 4:15 pm
Portfolio Pulse from Benzinga Newsdesk
November 07, 2023 | 1:02 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.